Hebei Medical University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1894-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.hebmu.edu.cn
Enhanced Recovery After Surgery Promotes the Rehabilitation of Patients With Acute Gastrointestinal Perforation in Perioperative Period
Not Applicable
Completed
- Conditions
- Acute Gastrointestinal PerforationEnhanced Recovery After Surgery
- First Posted Date
- 2025-06-06
- Last Posted Date
- 2025-06-06
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 362
- Registration Number
- NCT07008313
- Locations
- 🇨🇳
the Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Ultrasound-guided Biliary Drainage Improving Prognosis in the Frail and High Risk Elderly Patients
Not Applicable
Completed
- Conditions
- Biliary Tract Infection
- First Posted Date
- 2025-05-07
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 120
- Registration Number
- NCT06960486
- Locations
- 🇨🇳
The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Clinical Study of Double-Endoscopic Combined With Minimally Invasive Treatment for Early Gastric Cancer at Clinical Stage T1b
Not Applicable
Not yet recruiting
- Conditions
- Gastric Cancer Patients Undergoing Minimally Invasive Gastrectomy
- First Posted Date
- 2025-04-18
- Last Posted Date
- 2025-04-18
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 60
- Registration Number
- NCT06934824
Development and Application of an Artificial Intelligence-driven Accurate Identification Model for Gastric Cancer Lymph Node Metastasis
Recruiting
- Conditions
- The Primary Focus of This Study is on Gastric Cancer
- First Posted Date
- 2024-08-02
- Last Posted Date
- 2024-08-02
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 300
- Registration Number
- NCT06534814
- Locations
- 🇨🇳
Department of General Surgery, Shijiazhuang, Hebei, China
Exploratory Study of Single-port Robot-assisted Gastrectomy
Not Applicable
Not yet recruiting
- Conditions
- Gastric Cancer
- Interventions
- Device: SHURUI Endoscopic Surgical Robotic System (SR-ENS-600)
- First Posted Date
- 2024-01-11
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 10
- Registration Number
- NCT06201585
- Locations
- 🇨🇳
Department of General Surgery, Shijiazhuang, Hebei, China
Early Brain Damage Assessment in Aneurysmal Subarachnoid Haemorrhage in Predicting Cognitive Impairment
Completed
- Conditions
- Aneurysmal Subarachnoid Hemorrhage
- First Posted Date
- 2023-12-15
- Last Posted Date
- 2023-12-21
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 202
- Registration Number
- NCT06172556
- Locations
- 🇨🇳
The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Exploratory Study of Toumai Endoscopic Surgery System for Remote Gastrectomy
Not Applicable
Recruiting
- Conditions
- Gastric Cancer
- Interventions
- Device: Toumai Endoscopic surgery System
- First Posted Date
- 2023-10-10
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 10
- Registration Number
- NCT06073483
- Locations
- 🇨🇳
Department of General Surgery, Shijiazhuang, Hebei, China
Application and Research of Mesenchymal Stem Cells in Alleviating Severe Development of COVID-19 Infection
Phase 1
Recruiting
- Conditions
- COVID-19
- Interventions
- Other: ComparatorBiological: Umbilical cord mesenchymal stem cells implantation
- First Posted Date
- 2023-02-23
- Last Posted Date
- 2023-02-23
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 20
- Registration Number
- NCT05741099
- Locations
- 🇨🇳
The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Robot-assisted D2 Distal Gastrectomy Following Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancers
Not Applicable
Recruiting
- Conditions
- Gastric Cancer
- Interventions
- Procedure: Robot-assisted D2 distal gastrectomy
- First Posted Date
- 2023-02-15
- Last Posted Date
- 2023-02-15
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 70
- Registration Number
- NCT05728606
- Locations
- 🇨🇳
Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Nab-paclitaxel Plus Camrelizumab and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells
- First Posted Date
- 2022-06-08
- Last Posted Date
- 2022-06-24
- Lead Sponsor
- Hebei Medical University
- Target Recruit Count
- 30
- Registration Number
- NCT05410847